A carregar...
Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis
INTRODUCTION: Maximizing responses of malignant gliomas is hampered by resistance to temozolomide (TMZ). Increasing efficacy but not toxicity is a key issue when testing drug combinations. The antimyeloma agent bortezomib (BZ) has shown promising results in vitro and is currently being tested in gli...
Na minha lista:
| Publicado no: | Arch Med Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4424237/ https://ncbi.nlm.nih.gov/pubmed/25995745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2013.36919 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|